Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas.
Clinical trial NCT03115138 · TERMINATED
Trial details
- NCT number
- NCT03115138
- Sponsor
- Centre Hospitalier Universitaire, Amiens
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-09
- Primary completion
- 2017-11-06
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.